Lv13
40 积分 2023-04-28 加入
Teclistamab, a B-cell maturation antigen × CD3 bispecific antibody, in patients with relapsed or refractory multiple myeloma (MajesTEC-1): a multicentre, open-label, single-arm, phase 1 study
1天前
已完结
Human kallikrein 2: A novel lineage-specific surface target in prostate cancer
2天前
已完结
Proximity between LAG-3 and the T cell receptor guides suppression of T cell activation and autoimmunity
15天前
已完结
Safety and efficacy of the anti-TL1A monoclonal antibody tulisokibart for Crohn's disease: a phase 2a induction trial
20天前
已完结
皖公网安备34019202002308
